Clinical Trials Update: July 1, 2004
Keratoses Epilepsy Uterine Fibroids
(HealthDayNews) -- Here are the latest clinical trials, courtesy of CenterWatch:
A research study evaluating the safety and efficacy of an investigational medicated cream for actinic keratosis on the face or balding scalp. Actinic keratosis is one of the most common precancerous skin conditions. Patches of rough skin or marks on the face or balding scalp may be signs of actinic keratosis. Research site located in Chaska, Minn.
A research study to evaluate the effects of two FDA-approved drugs in patients with partial seizures. Volunteers 16 or older who have a confident diagnosis of epilepsy and who have experienced at least two simple partial or complex partial seizures in the previous six months may be eligible. Research sites located throughout the United States.
A research study of an investigational medication for the treatment of uterine fibroids. Women 18 or older who have regular, heavy menstrual cycles (21 to 35 days) may be eligible. Research site located in Laurel, Md.
Copyright 2004 CenterWatch. All rights reserved.